Apogee Therapeutics, Inc. Depreciation
Apogee Therapeutics, Inc. (APGE) reported Depreciation of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-10
- Apogee Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $400.00K, a 0.00% change year-over-year.
- Apogee Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $408.00K, a 97.10% increase year-over-year.
- Apogee Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $406.00K, a 434.21% increase year-over-year.
- Apogee Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $400.00K, a 733.33% increase year-over-year.
- Apogee Therapeutics, Inc. depreciation for fiscal 2025 was $1.42M, a 650.26% increase from fiscal 2024.
- Apogee Therapeutics, Inc. depreciation for fiscal 2024 was $189.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-10 | $817.00K 10-Q · filed 2026-08-10 | $1.21M derived: sum of 3 quarters · filed 2026-08-10 | $1.61M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $408.00K 10-Q · filed 2026-05-11 | $814.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.21M derived: sum of 3 quarters · filed 2026-05-11 | $1.61M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $806.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.21M derived: sum of 3 quarters · filed 2026-08-10 | $1.42M 10-K · filed 2026-03-02 |
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-10 | $800.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.01M 10-Q · filed 2025-11-10 | $1.08M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-10 | $606.00K 10-Q · filed 2026-08-10 | $683.00K derived: sum of 3 quarters · filed 2026-08-10 | $731.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $207.00K 10-Q · filed 2026-05-11 | $283.00K derived: sum of 2 quarters · filed 2026-05-11 | $331.00K derived: sum of 3 quarters · filed 2026-05-11 | $367.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $124.00K derived: sum of 2 quarters · filed 2026-03-02 | $160.00K derived: sum of 3 quarters · filed 2026-03-02 | $189.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $84.00K derived: sum of 2 quarters · filed 2025-11-10 | $113.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $65.00K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-12 |